Novavax Inc (NVAX.O)

NVAX.O on Nasdaq

4.99USD
23 Oct 2014
Price Change (% chg)

-- (--)
Prev Close
$4.99
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
3,258,415
52-wk High
$6.95
52-wk Low
$2.68

NVAX.O

Chart for NVAX.O

About

Novavax, Inc. (Novavax) is a clinical stage biopharmaceutical company. The Company focuses on developing recombinant vaccines. The Company’s technology platform is based on recombinant vaccine technology that includes the virus-like particles (VLPs). The Company's vaccine candidates are genetically engineered three-dimensional... (more)

Overall

Beta: 1.21
Market Cap (Mil.): $1,189.68
Shares Outstanding (Mil.): 238.41
Dividend: --
Yield (%): --

Financials

  NVAX.O Industry Sector
P/E (TTM): -- 152.31 33.65
EPS (TTM): -0.31 -- --
ROI: -32.45 -1.40 17.48
ROE: -34.78 -6.49 18.31
Search Stocks

Competitors

  Price Change
Novartis AG (NOVN.VX) CHF85.55 +0.15
Merck & Co., Inc. (MRK.N) $56.63 +1.12
Sanofi SA (SASY.PA) €84.59 -0.31
GlaxoSmithKline plc (GSK.L) 1,417.00p +5.00
AstraZeneca plc (AZN.L) 4,300.00p -34.50

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: New Constructs, LLC
$25.00
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks